Parallel routes of human carcinoma development: Implications of the age-specific incidence data

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Brody, James P ^a  

^a University of California at Irvine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER REGISTRY; CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DISEASE SURVEILLANCE; HUMAN; HYPOTHESIS; INTERNAL CONSISTENCY; LUNG CARCINOMA; MATHEMATICAL ANALYSIS; PARALLEL ROUTE HYPOTHESIS; PROSTATE CARCINOMA; RACE DIFFERENCE; AGE; AGING; CARCINOMA; CELL TRANSFORMATION; COMPUTER SIMULATION; GENETIC PREDISPOSITION; INCIDENCE; MIDDLE AGED; NEOPLASM; THEORETICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; COMPUTER SIMULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASMS; SEER PROGRAM;

EID: 70349613019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007053     Document Type: Article

References (51)

1. Farber E (1984) The multistep nature of cancer development. Cancer Res 44: 4217-4223.
2. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9: 138-141.
3. Nordling CO (1953) A new theory on cancer-inducing mechanism. Br J Cancer 7: 68-72.
4. Armitage P, Doll R (1954) The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8: 1-12.
5. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, et al. (2002) Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346: 311-320.
6. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, Rycke YD, et al. (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A 94: 12122-12127.
7. Pompei F, Wilson R (2002) A quantitative model of cellular senescence influence on cancer and longevity. Toxicol Ind Health 18: 365-376.
8. Frank SA (2004) Age-specific acceleration of cancer. Curr Biol 14: 242-246.
9. Holford TR, Cronin KA, Mariotto AB, Feuer EJ (2006) Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr. pp 19-25.
10. Pfeiffer RM, Mitani A, Matsuno RK, Anderson WF (2008) Racial differences in breast cancer trends in the united states (2000-2004). J Natl Cancer Inst 100: 751-752.
11. Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science.
12. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
13. Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1: 157-162.
14. Colditz GA, Rosner BA (2006) What can be learnt from models of incidence rates? Breast Cancer Res 8: 208.
15. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68: 820-823.
16. Hahn WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347: 1593-1603.
17. Surveillance, Epidemiology, End Results (SEER) Program (2003) Seerstat database: Incidence-SEER 9 regs public-use (www.seer.cancer.gov). Nov 2002 Sub (1973-2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission..
18. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, et al. (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161.
19. de Waard F (1979) Premenopausal and postmenopausal breast cancer: one disease or two? J Natl Cancer Inst 63: 549-552.
20. Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer 74: 1796-1800.
21. Anderson WF, Matsuno R (2006) Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 98: 948-951.
22. Johnson SM, Shaw JA, Walker RA (2002) Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int J Cancer 98: 205-209.
23. Weber-Mangal S, Sinn H, Popp S, Klaes R, Emig R, et al. (2003) Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization. Int J Cancer 107: 583-592.
24. Chung M, Chang HR, Bland KI, Wanebo HJ (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77: 97-103.
25. Xiong Q, Valero V, Kau V, Kau SW, Taylor S, et al. (2001) Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer 92: 2523-2528.
26. Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database. Breast Cancer Res Treat 76: 27-36.
27. Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA (2001) Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J Clin Oncol 19: 18-27.
28. Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1899-1905.
29. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, et al. (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279: 915-921.
30. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, et al. (1994) Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272: 947-954.
31. Jatoi I, Becher H, Leake CR (2003) Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Cancer 98: 894-899.
32. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, et al. (2007) Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 357: 775-788.
33. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in fgfr2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
34. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39: 645-649.
35. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, et al. (2008) Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 100: 1771-1779.
36. Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26: 411-414.
37. Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF, et al. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31: 33-36.
38. Herrero-Jimenez P, Thilly G, Southam PJ, Tomita-Mitchell A, Morgenthaler S, et al. (1998) Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States. Mutat Res 400: 553-578.
39. Herrero-Jimenez P, Tomita-Mitchell A, Furth EE, Morgenthaler S, Thilly WG (2000) Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States. Mutat Res 447: 73-116.
40. Moolgavkar SH, Luebeck G (1990) Two-event model for carcinogenesis: biological, mathematical, and statistical considerations. Risk Anal 10: 323-341.
41. Moolgavkar SH, Luebeck EG (1992) Multistage carcinogenesis: population-based model for colon cancer. J Natl Cancer Inst 84: 610-618.
42. Moolgavkar SH, Luebeck EG (2003) Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer 38: 302-306.
43. Luebeck EG, Moolgavkar SH (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A 99: 15095-15100.
44. Meza R, Jeon J, Moolgavkar SH, Luebeck EG (2008) Age-specific incidence of cancer: Phases, transitions, and biological implications. Proc Natl Acad Sci U S A 105: 16284-16289.
45. Frank SA, Chen PC, Lipkin SM (2005) Kinetics of cancer: a method to test hypotheses of genetic causation. BMC Cancer 5: 163.
46. Frank SA (2007) Dynamics of Cancer: Incidence, Inheritance, and Evolution. Princeton University Press.
47. Houlston RS, Peto J (2004) The search for low-penetrance cancer susceptibility alleles. Oncogene 23: 6471-6476.
48. Frank SA, Nowak MA (2003) Cell biology: Developmental predisposition to cancer. Nature 422: 494.
49. Heidenreich WF, Luebeck EG, Hazelton WD, Paretzke HG, Moolgavkar SH (2002) Multistage models and the incidence of cancer in the cohort of atomic bomb survivors. Radiat Res 158: 607-614.
50. Fay MP, Feuer EJ (1997) Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 16: 791-801.
51. Armitage P, Doll R (1957) A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer 11: 161-169.